Download presentation
Presentation is loading. Please wait.
Published byAmberly Perry Modified over 8 years ago
1
Macular Degeneration
2
Macular Degeneration Symptoms
3
Macular Degeneration Treatment
5
Ranibizumab (Lucentis)Pegaptanib (Macugen) Antibody fragment that binds to VEGF-A isoforms Oligonucleotide that binds to VEGF-165 Loading phase of one injection per month for 3 consecutive months, followed by a maintenance phase Intravitreal injection into the affected eye administered once every 6 weeks (9 injections per year) Cost per injection = £761.20 2-year cost up to £18,300 assuming 12 injections in the first year and another 12 in the second year Cost per injection = £514.00 2-year cost up to £9,300 assuming 9 injections in the first year and another 9 in the second year
6
TA 155 Ranibizumab and pegaptanib for the treatment of age-related macular degeneration Full url- http://publications.nice.org.uk/ranibizumab- and-pegaptanib-for-the-treatment-of-age- related-macular-degeneration-ta155 http://publications.nice.org.uk/ranibizumab- and-pegaptanib-for-the-treatment-of-age- related-macular-degeneration-ta155
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.